Search Within

David Scheinberg

  1. "Breast Medicine Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (7)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  3. Breast Medicine Service (7)
  4. Center for Hematologic Malignancies (7)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  6. Department of Medicine (7)

More Groups

People
  1. Christopher Klebanoff (4)
  2. Martin Klatt (4)
  3. Smita Chandran (4)
  4. Aaron Chang (2)
  5. Claire Oh (2)
  6. Matthew Femia (2)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2016 (1)
  5. 1998 (1)
  6. 1994 (1)
Publications
  1. Cancer Immunology Research (2)
  2. Blood (1)
  3. Journal for ImmunoTherapy of Cancer (1)
  4. Leukemia (1)
  5. Molecular Cancer Therapeutics (1)
  6. Nature Medicine (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Nature Publishing Group (2)
  3. American Society of Hematology (1)
  4. Biomed Central Ltd (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
    Journal Article

    Chandran, S. S.; Ma, J.; Klatt, M. G.; Dündar, F.; Bandlamudi, C.; Razavi, P.; Wen, H. Y.; Weigelt, B.; Zumbo, P.; Fu, S. N.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Identification of the targets of T-cell receptor therapeutic agents and cells by use of a high-throughput genetic platform
    Journal Article

    Gejman, R. S.; Jones, H. F.; Klatt, M. G.; Chang, A. Y.; Oh, C. Y.; Chandran, S. S.; Korontsvit, T.; Zakahleva, V.; Dao, T.; Klebanoff, C. A.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Kinase regulation of human MHC class i molecule expression on cancer cells
    Journal Article

    Brea, E. J.; Oh, C. Y.; Manchado, E.; Budhu, S.; Gejman, R. S.; Mo, G.; Mondello, P.; Han, J. E.; Jarvis, C. A.; Ulmert, D.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia
    Journal Article

    Weiss, M. A.; Drullinsky, P.; Maslak, P.; Scheinberg, D.; Golde, D. W.
    Leukemia (1998)

    Fulltext@MSK | Save
  • Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid
    Journal Article

    Vahdat, L.; Maslak, P.; Miller, W. H. Jr; Eardley, A.; Heller, G.; Scheinberg, D. A.; Warrell, R. P. Jr
    Blood (1994)

    Fulltext@MSK | Save